HK1082923A1 - Synergistic compositions for the prevention and treatment of acquired immunodeficiency - Google Patents

Synergistic compositions for the prevention and treatment of acquired immunodeficiency

Info

Publication number
HK1082923A1
HK1082923A1 HK06102937A HK06102937A HK1082923A1 HK 1082923 A1 HK1082923 A1 HK 1082923A1 HK 06102937 A HK06102937 A HK 06102937A HK 06102937 A HK06102937 A HK 06102937A HK 1082923 A1 HK1082923 A1 HK 1082923A1
Authority
HK
Hong Kong
Prior art keywords
prevention
treatment
acquired immunodeficiency
synergistic compositions
synergistic
Prior art date
Application number
HK06102937A
Other languages
English (en)
Inventor
Fung Sek Chung
Original Assignee
Tanox Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Tanox Inc filed Critical Tanox Inc
Publication of HK1082923A1 publication Critical patent/HK1082923A1/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39541—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against normal tissues, cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses
    • A61P31/18—Antivirals for RNA viruses for HIV
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Immunology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Molecular Biology (AREA)
  • AIDS & HIV (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
HK06102937A 2002-09-27 2006-03-07 Synergistic compositions for the prevention and treatment of acquired immunodeficiency HK1082923A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US41406202P 2002-09-27 2002-09-27
PCT/US2003/030538 WO2004028473A2 (en) 2002-09-27 2003-09-26 Synergistic compositions for the prevention and treatment of acquired immunodeficiency syndrome

Publications (1)

Publication Number Publication Date
HK1082923A1 true HK1082923A1 (en) 2006-06-23

Family

ID=32043337

Family Applications (1)

Application Number Title Priority Date Filing Date
HK06102937A HK1082923A1 (en) 2002-09-27 2006-03-07 Synergistic compositions for the prevention and treatment of acquired immunodeficiency

Country Status (12)

Country Link
US (1) US20060121480A1 (zh)
EP (1) EP1543166A4 (zh)
JP (1) JP2006503849A (zh)
CN (3) CN101152574A (zh)
AP (1) AP2005003294A0 (zh)
AU (1) AU2003299085B2 (zh)
BR (1) BR0314711A (zh)
CA (1) CA2498483A1 (zh)
HK (1) HK1082923A1 (zh)
MX (1) MXPA05002851A (zh)
WO (1) WO2004028473A2 (zh)
ZA (1) ZA200502464B (zh)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2002096935A2 (en) 2001-05-31 2002-12-05 Conjuchem, Inc. Long lasting fusion peptide inhibitors for hiv infection
CA2565658A1 (en) * 2004-05-06 2005-11-17 Conjuchem Biotechnologies Inc. Compounds for specific viral target
JP2010500984A (ja) * 2006-08-17 2010-01-14 エフ．ホフマン−ラ ロシュ アーゲー Ｃｃｒ５に対する抗体と抗膜融合ペプチドとの抱合体
TW200817438A (en) * 2006-08-17 2008-04-16 Hoffmann La Roche A conjugate of an antibody against CCR5 and an antifusogenic peptide
AR067584A1 (es) 2007-07-20 2009-10-14 Hoffmann La Roche Un conjugado de un anticuerpo contra la cd4 y peptidos antifusogenicos
RU2517084C2 (ru) * 2010-08-06 2014-05-27 Олег Ильич Эпштейн Способ и средство для ингибирования продукции или усиления элиминации белка р24
CN106139150B (zh) * 2015-04-10 2019-10-08 复旦大学 一种艾滋病治疗性疫苗组合物及其应用
JP6894846B2 (ja) * 2015-04-24 2021-06-30 ヴィーブ ヘルスケア ユーケー（ナンバー５）リミテッド Ｈｉｖ融合体を標的とするポリペプチド

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPH06502539A (ja) * 1990-10-26 1994-03-24 ザ・パブリック・ヘルス・リサーチ・インスティチュート・オブ・ザ・シティ・オブ・ニューヨーク・インコーポレーテッド Ｈｉｖ−１　ｇｐ１２０のｖ３ループおよびｃｄ−４結合部位に特異的な中和ヒトモノクローナル抗体
DE69126301T2 (de) * 1990-11-27 1998-01-02 Biogen, Inc., Cambridge, Mass. Hiv-induzierte synzytien blockierender anti-cd-4-antikörper
US6136310A (en) * 1991-07-25 2000-10-24 Idec Pharmaceuticals Corporation Recombinant anti-CD4 antibodies for human therapy
US5397703A (en) * 1992-07-09 1995-03-14 Cetus Oncology Corporation Method for generation of antibodies to cell surface molecules
US5817767A (en) * 1993-02-24 1998-10-06 Progenics Pharmaceuticals, Inc. Synergistic composition of CD4-based protein and anti-HIV-1 antibody, and methods of using same
US5464933A (en) * 1993-06-07 1995-11-07 Duke University Synthetic peptide inhibitors of HIV transmission
AU723537B2 (en) * 1995-06-07 2000-08-31 Trimeris Inc. The treatment of HIV and other viral infections using combinatorial therapy
US7122185B2 (en) * 2002-02-22 2006-10-17 Progenics Pharmaceuticals, Inc. Anti-CCR5 antibody

Also Published As

Publication number Publication date
WO2004028473A2 (en) 2004-04-08
AU2003299085A1 (en) 2004-04-19
CN100341573C (zh) 2007-10-10
AP2005003294A0 (en) 2005-06-30
CN101152574A (zh) 2008-04-02
AU2003299085B2 (en) 2008-04-10
JP2006503849A (ja) 2006-02-02
WO2004028473A3 (en) 2004-12-09
BR0314711A (pt) 2005-07-26
CA2498483A1 (en) 2004-04-08
CN101152573A (zh) 2008-04-02
MXPA05002851A (es) 2005-09-08
EP1543166A4 (en) 2009-10-28
US20060121480A1 (en) 2006-06-08
CN1685064A (zh) 2005-10-19
EP1543166A2 (en) 2005-06-22
ZA200502464B (en) 2005-11-01

Similar Documents

Publication Publication Date Title
HK1152474A1 (zh) 用於預防和治療膿毒症的方法和組合物
HRP20130602T1 (en) 2,4-pyrimidinediamine compounds for use in the treatment or prevention of autoimmune diseases
IL162838A0 (en) Compositions and methods for prevention and treatment peptide-of amyloid- related disorders
EP1753777A4 (en) METHOD AND COMPOSITIONS FOR TREATING AND PREVENTING HIV INFECTION WITH TRIM5a
EP1578437A4 (en) COMPOSITIONS AND METHODS FOR PREVENTING AND REDUCING INSULIN-INDUCED HYPOGLYCEMIA
AU2003205737A1 (en) Compositions comprising lycopene for the treatment and prevention of angiogenesis associated pathologies
EG23626A (en) Synergistic seed treatment compositions
IL158181A0 (en) N-acetylcysteine compositions and methods for the treatment and prevention of drug toxicity
TWI347188B (en) Treatment and prevention of osteoporosis
AU2003274342A8 (en) Compositions for the treatment of autoimmune disorders
HK1082923A1 (en) Synergistic compositions for the prevention and treatment of acquired immunodeficiency
AU2003291480A8 (en) Composition for the prevention and treatment of inflammation of the ear
AU2003211610A1 (en) Pharmaceutical compositions for the treatment or prevention of osteoporosis
IL161091A0 (en) Compositions for the treatment and prevention of plant pathogens
HUP0300990D0 (en) Synergistic combination for the prophylaxis and treatment of diabetes
EP1671648A4 (en) PREVENTION AND TREATMENT OF GVHD
AU2003240174A8 (en) Compositions for the treatment of edematous-firbrosclerotic panniculopathy
MXPA03006468A (es) Composiciones para la prevencion o tratamiento de hepatopatia.
GB0313630D0 (en) Compositions for the enhanced treatment of depression
AU2003291461A8 (en) Compositions for diabetes treatment and prophylaxis
HK1079693A1 (en) Compositions for treating and/or preventing pollenosis
AU2003301170A8 (en) Compositions for the treatment and prevention of nephropathy
IL151658A0 (en) Methods and compositions for the treatment or prevention of cardiovascular diseases
EP1581246A4 (en) COMPOSITIONS FOR THE TREATMENT AND PREVENTION OF NEPHROPATHY
AU2003220601A8 (en) Synergistic l-methadone compositions and methods of use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20110926